Africa Alzheimer’s Disease Drugs Market

Africa Alzheimer’s Disease Drugs Market


$ 3999

The Africa Alzheimer’s Disease Drugs market was valued at $231 Mn in 2022 and is estimated to expand at a CAGR of 9.92% from 2022-30 and will reach $493 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are AbbVie, AstraZeneca, Biogen, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, and Pfizer among others.

ID: IN10AFPH006 CATEGORY: Pharmaceuticals GEOGRAPHY: Africa AUTHOR: Nandini Shah

Buy Now

Africa Alzheimer’s Disease Drugs Market Executive Summary

The Africa Alzheimer’s Disease Drugs market was valued at $231 Mn in 2022 and is estimated to expand at a CAGR of 9.92% from 2022-30 and will reach $493 Mn in 2030. Alzheimer's disease causes the brain to shrink and, eventually, brain cells to die. Alzheimer's disease is the most prevalent cause of dementia, which is characterized by a progressive decline in memory, thinking, behavior, and social skills. These alterations have an impact on a person's ability to operate.

Alzheimer's disease, other dementias, and non-communicable diseases are expected to place an increasing burden on healthcare systems across Sub-Saharan Africa as populations age and communicable disease mortality and morbidity fall. More than half of all dementia patients live in low- and middle-income countries. According to a recent Alzheimer's Disease International report, the age-adjusted dementia prevalence in Sub-Saharan Africa among people aged 60 and above is 7.2%.

africa alzheimers disease drugs market

Market Dynamics

Market Growth Drivers

As of 2020, there will be 74.4 million people 60 and older in Africa (54.3 million in Sub-Saharan Africa), with populations of at least one million in 18 nations (U.S. Census Bureau, 2019), and the region is expected to triple in size from 74.4 million to 235.1 million, outpacing all other regions in terms of population growth among older adults. As the population of Africa continues to age, the number of people with Alzheimer's disease is expected to increase significantly. This is one of the primary drivers of growth in the Alzheimer's drugs market in Africa. In recent years, there has been a growing awareness of Alzheimer's disease in Africa, which has led to increased diagnosis and treatment of the disease. This increased awareness is expected to drive growth in the market for Alzheimer's drugs in the region.

As countries in Africa continue to invest in their healthcare systems, more resources are being directed toward the diagnosis and treatment of Alzheimer's disease. This increased healthcare expenditure is expected to drive growth in the market for Alzheimer's drugs in the region. Several governments in Africa have launched initiatives aimed at improving access to Alzheimer's drugs in their countries. This support from governments is expected to drive growth in the market for Alzheimer's drugs in Africa. The development of new technologies and therapies for the treatment of Alzheimer's disease is expected to drive growth in the market for Alzheimer's drugs in Africa. As new and more effective treatments become available, demand for these drugs is likely to increase.

Market Restraints

There is still a limited amount of research and development focused on Alzheimer's disease in Africa. This can limit the availability of new and innovative treatments for the disease in the region. The regulatory environment for Alzheimer's drugs in Africa can be challenging, with varying regulations and standards across different countries. This can make it difficult for pharmaceutical companies to navigate the market and launch new drugs. There is still a relatively low level of awareness and education about Alzheimer's disease in Africa. This can make it difficult for patients and their families to recognize the signs and symptoms of the disease, leading to delays in diagnosis and treatment. Many countries in Africa have limited healthcare infrastructure, which can make it difficult to diagnose and treat Alzheimer's disease effectively. This can lead to delays in diagnosis and treatment, which can worsen the progression of the disease. The high cost of Alzheimer's drugs is a major challenge in Africa, where many patients cannot afford these medications. This makes it difficult for them to access the treatment they need, leading to low levels of diagnosis and treatment of the disease.

Competitive Landscape

Key Players

  • Abbvie
  • AstraZeneca
  • Aspen
  • BGM
  • Ferring
  • GlaxoSmithKline
  • Novartis.
  • Biogen
  • Eisai Co.
  • Eli Lilly and Company
  • H. Lundbeck A/S
  • Johnson and Johnson
  • F. Hoffmann-La Roche AG
  • Merck & Co.
  • Novartis AG
  • Pfizer

Healthcare Policies and Regulatory Landscape

The African Medicines Regulatory Harmonization (AMRH) initiative is a collaborative initiative that aims to improve the regulatory framework for pharmaceuticals in Africa by promoting the harmonization of regulatory standards and processes across the continent. The initiative is supported by the African Union, the WHO, and other partners, and aims to improve access to safe and effective medicines for all Africans. The African Union also plays a role in setting policies and guidelines related to healthcare and pharmaceuticals and works to promote access to essential medicines and health technologies.

The organization has formal ties with the World Health Organization. ADI fights for those suffering from Alzheimer’s Disease and other forms of dementia. The organization works to make dementia an Africa, regional, and local priority by empowering Alzheimer’s Disease and dementia associations to advocate for dementia as a national priority, raise awareness, and provide care and support to people with dementia and their careers, as well as lobbying governments for better policy and encouraging investment and innovation in dementia research. The Alzheimer’s Disease Association also collaborates with other international organizations and initiatives focused on Alzheimer’s Disease and dementia, such as the World Health Organization (WHO) and the Africa Alzheimer’s Disease and Dementia Action Alliance (GADAA).

Reimbursement Scenario

The reimbursement scenario for healthcare products and services, including Alzheimer's drugs, in Africa varies widely from country to country and is influenced by a range of factors, including the availability of resources, political and economic conditions, and cultural traditions. In general, many African countries have limited resources to invest in healthcare, which can make it difficult to provide universal access to healthcare products and services, including Alzheimer's drugs. As a result, many people in Africa may have to pay out of pocket for these products, which can be a significant burden for families and caregivers. In addition, there are some international organizations and non-governmental organizations (NGOs) that work to improve access to healthcare products and services in Africa, including Alzheimer's drugs. These organizations may provide funding or other forms of support to help make these products more affordable and accessible to patients in need.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Alzheimer’s Disease Drugs Market Segmentation

By Drug Class (Revenue, USD Billion):

  • Cholinesterase Inhibitors (Donepezil, Rivastigmine, Galantamine)
  • N-Methyl-D-Aspartate (NMDA) Receptor Antagonists (Memantine)
  • Combination Drugs
  • Others (Lecanemab, Aducanumab)

Drug segmentation is the process of dividing a set of drugs into different categories or classes based on their pharmacological properties, therapeutic uses, and other characteristics. Here, Alzheimer’s Disease Drugs Market is segmented into Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Combination Drugs, and others like (Lecanemab, Aducanumab)

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Route of Administration

  • Oral
  • Transdermal
  • Intravenous

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 13 March 2023
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up